Northwestern Mutual Wealth Management
PYXS icon

Northwestern Mutual Wealth Management’s Pyxis Oncology PYXS Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$14 – 4408
2025
Q4 		$14 Hold
12
– – ﹤0.01% 3964
2025
Q3 		$27 Hold
12
– – ﹤0.01% 3748
2025
Q2 		$13 Hold
12
– – ﹤0.01% 3623
2025
Q1 		$12 Hold
12
– – ﹤0.01% 3620
2024
Q4 		$19 Buy
+12
New +$35 ﹤0.01% 3546
2024
Q3 		– Sell
-250
Closed -$828 – 3809
2024
Q2 		$828 Buy
+250
New +$1.05K ﹤0.01% 3234

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwestern Mutual Wealth Management's PYXS Position: Q1 2026 in Review

Northwestern Mutual Wealth Management sold out of Pyxis Oncology (PYXS) in Q1 2026, closing a stake of 12 shares — an estimated $14 sold.

Northwestern Mutual Wealth Management first reported a position in PYXS in Q2 2024 and held it in 6 quarters. The position peaked at $828 in Q2 2024. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Northwestern Mutual Wealth Management reported no remaining Pyxis Oncology position as of Q1 2026 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 12 Pyxis Oncology shares in Q1 2026, an estimated $14.
  • Northwestern Mutual Wealth Management first reported a position in Pyxis Oncology in Q2 2024 and held it in 6 quarters.
  • Northwestern Mutual Wealth Management's Pyxis Oncology position peaked at $828 in Q2 2024.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.